Low Dose IL-2 and Rapamycin Protects Against Human Islet Allograft Rejection and Inhibit IFN-γ Producing T Cells in a Humanized Diabetic Mouse Model.
Hu, M., Hawthorne, W., Nan, H., Wu, J., Liuwantara, D., Qian, Y., YI, S., Alexander, S., OʼConnell, P.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-01148
Date:
July, 2014
File:
PDF, 216 KB
2014